University of Edinburgh
Genomic analysis of dysplastic lesions in Inflammatory bowel disease
Abstract
dc:description.abstractInflammatory bowel disease (IBD)-associated dysplasia refers to precancerous abnormal cell growth in the colorectal epithelium of individuals with chronic IBD. Current methods for predicting colorectal cancer risk in patients with IBD-associated low-grade dysplasia are limited, and its molecular landscape remains underexplored. This study utilises whole exome sequencing of longitudinal, histopathologically graded dysplastic lesions to comprehensively analyse the genetic alterations and molecular characteristics underlying dysplasia and cancer progression. Lesions that progressed to high-grade dysplasia or carcinoma exhibited a higher frequency of TP53 mutations and widespread DNA copy number alterations compared with lesions that did not progress. These findings support TP53 mutation and genomic instability as key early drivers of neoplastic progression in IBD. Incorporating genomic testing for copy number alterations and TP53 mutations could improve clinical risk stratification and inform more personalised surveillance and management strategies for patients with IBD-associated dysplasia.
Author and committee
dc:creator, dc:contributor.*- Author dc:creator
-
- Cheema, Saamin Akram
- Advisors dc:contributor.advisor
-
- Arends, Mark
- Adams, Dave
- Din, Shahida
Subjects
dc:subject × 5Rights
- Language dc:language.iso
- en
Identifiers
dc:identifier.*- Identifier URI
- https://doi.org/10.7488/era/7989